Delivery Order SPE2DB20D2104-SPE2DB25FLZWS
Award Date
10/7/24
Potential Completion Date
10/8/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Timolol 0.5% Gel-Solution (5ml) to support government healthcare programs. The $14,197.90 delivery order was issued by the Defense Logistics Agency (DLA) and has a January 2022 completion date. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The contract has a firm fixed price of $1,369.92 and a period of performance through May 14, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Timolol 0.5% gel-solution medical products to support military healthcare programs. The $3,005.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Timolol 0.5% Gel-Solution 5ml, a pharmaceutical product used to treat eye conditions. The Delivery Order has a ceiling value of $1,366.16 and an ultimate completion date of December 5, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Timolol 0.5% Gel-Solution, a topical eye medication, with a ceiling value of $5,624.58. The delivery order has an ultimate completion date of April 3, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide a pharmaceutical product, Timolol 0.5% GFS Gel-Solution 5ML, with a potential value of $1,224.59 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,833.35 firm fixed price contract is for the delivery of Timolol 0.25% Gel-Solution, a medication used to treat high eye pressure. The contract has an ultimate completion date of April 4, 2024. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The $1,936.67 Firm Fixed Price Delivery Order contract has an ultimate completion date of October 19, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,871.28 firm fixed-price delivery order is for the supply of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The award is not associated with a set-aside program and was issued as an individual delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award summarized is a Delivery Order (DO) with Amerisourcebergen Drug Corp as the prime contractor. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to provide Timolol 0.5% Gel-Solution 5ML, a pharmaceutical product. The DO has a firm fixed price of $5,457.86 and an ultimate completion date of November 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...